117 related articles for article (PubMed ID: 35917563)
1. Development of an Anti-human CCR2 Monoclonal Antibody (C
Tanaka T; Li G; Saito M; Suzuki H; Asano T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Aug; 41(4):188-193. PubMed ID: 35917563
[TBL] [Abstract][Full Text] [Related]
2. Development of a Novel Anti-Mouse CCR2 Monoclonal Antibody (C
Tanaka T; Li G; Asano T; Saito M; Kaneko MK; Suzuki H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):80-86. PubMed ID: 35377242
[TBL] [Abstract][Full Text] [Related]
3. Epitope Mapping of the Anti-Human CCR2 Monoclonal Antibody C
Tanaka T; Li G; Asano T; Kaneko MK; Suzuki H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):150-156. PubMed ID: 35666539
[TBL] [Abstract][Full Text] [Related]
4. Epitope Mapping of an Anti-Mouse CCR2 Monoclonal Antibody (C
Tanaka T; Suzuki H; Asano T; Li G; Nanamiya R; Tateyama N; Isoda Y; Okada Y; Kobayashi H; Yoshikawa T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):339-342. PubMed ID: 36346278
[TBL] [Abstract][Full Text] [Related]
5. Epitope Mapping of the Anti-Human CC Chemokine Receptor Type-2 Monoclonal Antibody (K036C2).
Tanaka T; Suzuki H; Li G; Nanamiya R; Isoda Y; Okada Y; Kobayashi H; Yoshikawa T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Oct; 41(5):285-289. PubMed ID: 36301190
[TBL] [Abstract][Full Text] [Related]
6. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
[TBL] [Abstract][Full Text] [Related]
7. Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C
Tanaka T; Suzuki H; Isoda Y; Asano T; Nakamura T; Yanaka M; Handa S; Takahashi N; Okuno S; Yoshikawa T; Li G; Nanamiya R; Goto N; Tateyama N; Okada Y; Kobayashi H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):303-310. PubMed ID: 36383113
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells.
Frade JM; Mellado M; del Real G; Gutierrez-Ramos JC; Lind P; Martinez-A C
J Immunol; 1997 Dec; 159(11):5576-84. PubMed ID: 9548499
[TBL] [Abstract][Full Text] [Related]
9. Development of a Novel Anti-Mouse CCR4 Monoclonal Antibody (C
Takei J; Suzuki H; Asano T; Tanaka T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):87-93. PubMed ID: 35471046
[TBL] [Abstract][Full Text] [Related]
10. Cx
Kitamura K; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):133-141. PubMed ID: 35736626
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
[TBL] [Abstract][Full Text] [Related]
12. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases.
Zhu S; Liu M; Bennett S; Wang Z; Pfleger KDG; Xu J
J Cell Physiol; 2021 Oct; 236(10):7211-7222. PubMed ID: 33782965
[TBL] [Abstract][Full Text] [Related]
13. Development of a Novel Anti-Mouse CCR6 Monoclonal Antibody (C
Asano T; Tanaka T; Suzuki H; Li G; Nanamiya R; Tateyama N; Isoda Y; Okada Y; Kobayashi H; Yoshikawa T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):343-349. PubMed ID: 36383115
[TBL] [Abstract][Full Text] [Related]
14. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2.
Shin N; Baribaud F; Wang K; Yang G; Wynn R; Covington MB; Feldman P; Gallagher KB; Leffet LM; Lo YY; Wang A; Xue CB; Newton RC; Scherle PA
Biochem Biophys Res Commun; 2009 Sep; 387(2):251-5. PubMed ID: 19576173
[TBL] [Abstract][Full Text] [Related]
16. Establishment of Novel Anti-Mouse CCR3 Monoclonal Antibodies (C
Asano T; Suzuki H; Goto N; Tanaka T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):94-100. PubMed ID: 35471054
[TBL] [Abstract][Full Text] [Related]
17. The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection.
Frade JM; Llorente M; Mellado M; Alcamí J; Gutiérrez-Ramos JC; Zaballos A; Real G; Martínez-A C
J Clin Invest; 1997 Aug; 100(3):497-502. PubMed ID: 9239395
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1).
Tan JHY; Ludeman JP; Wedderburn J; Canals M; Hall P; Butler SJ; Taleski D; Christopoulos A; Hickey MJ; Payne RJ; Stone MJ
J Biol Chem; 2013 Apr; 288(14):10024-10034. PubMed ID: 23408426
[TBL] [Abstract][Full Text] [Related]
19. Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.
Ben-Yehuda H; Arad M; Peralta Ramos JM; Sharon E; Castellani G; Ferrera S; Cahalon L; Colaiuta SP; Salame TM; Schwartz M
Mol Neurodegener; 2021 Jun; 16(1):39. PubMed ID: 34172073
[TBL] [Abstract][Full Text] [Related]
20. Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region.
Gilbert J; Lekstrom-Himes J; Donaldson D; Lee Y; Hu M; Xu J; Wyant T; Davidson M;
Am J Cardiol; 2011 Mar; 107(6):906-11. PubMed ID: 21247529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
